Company Overview and News
In the last five trading days, telecom stocks witnessed a sharp rise initially and maintained a flat trajectory thereafter as the Trump administration imposed tariffs on $34 billion worth of imported goods against China. The stocks resumed its ascent later in the week but slipped partially yesterday, as Washington issued a fresh threat to impose additional tariffs against the communist nation. At the stroke of midnight last Friday, the United States implemented its long- publicized trade tariffs against China, prompting a swift retaliation of the same magnitude by the latter.
CBS LMT CHLKF TMUSP CBS.A TMUS CBS.WD 0941 MSI CHL JNPR ADI NOKIA NOK CPV
Nokia Corporation (NOK - Free Report) recently inked an agreement with China Mobile Limited (CHL - Free Report) to carry out joint research to explore the potential of artificial intelligence (AI) and machine learning in 5G networks in China. The strategic framework aims to pool in resources of both the companies for the overall improvement of the industry and is likely to be a win-win deal. China Mobile is reportedly the largest telecom carrier in the world with about 899 million subscribers.
0941 MSI CHLKF CHL NOKIA UBNT NOK
Nokia Corporation (NOK - Free Report) recently inked an agreement with Tencent to carry out joint research and development work in 5G to benefit the Internet users of China. The strategic framework aims to pool in resources of both the companies for the overall improvement of the industry and is likely to be a win-win deal. Tencent, a leading Internet service provider in China, reportedly has more than 1 billion combined monthly active users in its WeChat and QQ social media applications.
MSI CMTL NOKIA UBNT NOK MRC
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
0941 CHLKF CHL GOOGL NOKIA NOK GOOG
Nokia Corporation (NOK - Free Report) recently entered into a strategic partnership with Sudatel — a telecommunications and Internet service provider, based in Sudan. Per the deal, both the companies will work on the development of ultra-broadband services in Sudan.
CMTL DB JNPR NOKIA UBNT NOK DLPH
Espoo, Finland - A total of 49 000 Nokia shares (NOKIA) held by the company were today transferred without consideration to participants of Nokia's equity-based incentive plans as settlement in accordance with the rules of the plans. The transfer is based on the resolution of the Board of Directors to issue shares held by the company to settle its commitments to the participants of the plans as announced on February 1, 2018.
In the last five trading days, telecom stocks declined initially but recovered steeply thereafter, only to partially lose ground later in the week due to the still looming trade war fears with China. The on-again off-again trade war between the United States and China continued to keep the stocks in hot water as both the warring nations vowed to impose tariffs and retaliatory tariffs on each other.
HCTHY GOOG BB BBRY VZA MSI VSAT GOOGL HCLTECH VZ NOKIA 532281 NOK QCOM BB SBAC
6h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
7h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to EPA:NOKIA / NOKIA on message board site Silicon Investor.
|Nokia Corp. (NOK)||Nokia (NOK)|
|NOKIA Bankruptcy Watch||Sonera (SNRA) : The next Nokia ?|
|NOKIA NEWS||NOK: Nokia Corporation|
|INFOWAVE u0026 NOKIA||Nokia|